153 related articles for article (PubMed ID: 35233765)
1. Perturbation of monoamine metabolism and enhanced fear responses in mice defective in the regeneration of tetrahydrobiopterin.
Miyajima K; Sudo Y; Sanechika S; Hara Y; Horiguchi M; Xu F; Suzuki M; Hara S; Tanda K; Inoue KI; Takada M; Yoshioka N; Takebayashi H; Mori-Kojima M; Sugimoto M; Sumi-Ichinose C; Kondo K; Takao K; Miyakawa T; Ichinose H
J Neurochem; 2022 Apr; 161(2):129-145. PubMed ID: 35233765
[TBL] [Abstract][Full Text] [Related]
2. Disturbed biopterin and folate metabolism in the Qdpr-deficient mouse.
Xu F; Sudo Y; Sanechika S; Yamashita J; Shimaguchi S; Honda S; Sumi-Ichinose C; Mori-Kojima M; Nakata R; Furuta T; Sakurai M; Sugimoto M; Soga T; Kondo K; Ichinose H
FEBS Lett; 2014 Nov; 588(21):3924-31. PubMed ID: 25240194
[TBL] [Abstract][Full Text] [Related]
3. Binding profile of quinonoid-dihydrobiopterin to quinonoid-dihydropteridine reductase examined by in silico and in vitro analyses.
Kono H; Hara S; Furuta T; Ichinose H
J Biochem; 2023 Oct; 174(5):441-450. PubMed ID: 37540845
[TBL] [Abstract][Full Text] [Related]
4. Molecular and metabolic bases of tetrahydrobiopterin (BH
Himmelreich N; Blau N; Thöny B
Mol Genet Metab; 2021 Jun; 133(2):123-136. PubMed ID: 33903016
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of QDPR synergistically modulates intracellular tetrahydrobiopterin profiles in cooperation with methotrexate.
Hara S; Kono H; Suto N; Kojima H; Kishimoto K; Yoshino H; Niiyama S; Kakihana Y; Ichinose H
Biochem Biophys Res Commun; 2024 Jul; 717():150059. PubMed ID: 38723517
[TBL] [Abstract][Full Text] [Related]
6. Quinonoid dihydropteridine reductase, a tetrahydrobiopterin-recycling enzyme, contributes to 5-hydroxytryptamine-associated platelet aggregation in mice.
Suganuma Y; Sumi-Ichinose C; Kano T; Ikemoto K; Matsui T; Ichinose H; Kondo K
J Pharmacol Sci; 2022 Nov; 150(3):173-179. PubMed ID: 36184122
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis, treatment and gene mutation analysis of the first case with dihydropteridine reductase deficiency in the mainland of China].
Ye J; Qiu WJ; Han LS; Zhang HW; Zhou JD; Gao XL; Wang Y; Gu XF
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):281-5. PubMed ID: 19099731
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of tetrahydrobiopterin (BH4) deficiency in the Maltese population.
Farrugia R; Scerri CA; Montalto SA; Parascandolo R; Neville BG; Felice AE
Mol Genet Metab; 2007 Mar; 90(3):277-83. PubMed ID: 17188538
[TBL] [Abstract][Full Text] [Related]
9. Genotypic variants of the tetrahydrobiopterin (BH4) biosynthesis genes in patients with hyperphenylalaninemia from different regions of Iran.
Nezhad SRK; Aligoodarzi PN; Rostami G; Shariati G; Galehdari H; Saberi A; Sedaghat A; Hamid M
Mol Genet Genomic Med; 2024 Jan; 12(1):e2294. PubMed ID: 37818795
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrobiopterin: biochemistry and pathophysiology.
Werner ER; Blau N; Thöny B
Biochem J; 2011 Sep; 438(3):397-414. PubMed ID: 21867484
[TBL] [Abstract][Full Text] [Related]
11. Disorders of tetrahydrobiopterin metabolism and their treatment.
Shintaku H
Curr Drug Metab; 2002 Apr; 3(2):123-31. PubMed ID: 12003346
[TBL] [Abstract][Full Text] [Related]
12. Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism.
Citron BA; Kaufman S; Milstien S; Naylor EW; Greene CL; Davis MD
Am J Hum Genet; 1993 Sep; 53(3):768-74. PubMed ID: 8352282
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
Thöny B; Ding Z; Martínez A
FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
[TBL] [Abstract][Full Text] [Related]
14. Administration of tetrahydrobiopterin restored the decline of dopamine in the striatum induced by an acute action of MPTP.
Kurosaki H; Yamaguchi K; Man-Yoshi K; Muramatsu SI; Hara S; Ichinose H
Neurochem Int; 2019 May; 125():16-24. PubMed ID: 30739038
[TBL] [Abstract][Full Text] [Related]
15. Disorders of Tetrahydrobiopterin Metabolism: Experience from South India.
Ray S; Padmanabha H; Gowda VK; Mahale R; Christopher R; Sreedharan S; Dhar D; Kamate M; Nagappa M; Bhat M; Anjanappa R; Arunachal G; Pooja M; Mathuranath PS; Chandra SR
Metab Brain Dis; 2022 Mar; 37(3):743-760. PubMed ID: 34997870
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of tetrahydrobiopterin: its relevance in monoaminergic neurons and neurological disorders.
Ichinose H; Nomura T; Sumi-Ichinose C
Chem Rec; 2008; 8(6):378-85. PubMed ID: 19107867
[TBL] [Abstract][Full Text] [Related]
17. Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria.
Michals-Matalon K
Expert Opin Investig Drugs; 2008 Feb; 17(2):245-51. PubMed ID: 18230057
[TBL] [Abstract][Full Text] [Related]
18. Genome sequencing identifies a homozygous inversion disrupting QDPR as a cause for dihydropteridine reductase deficiency.
Lilleväli H; Pajusalu S; Wojcik MH; Goodrich J; Collins RL; Murumets Ü; Tammur P; Blau N; Lilleväli K; Õunap K
Mol Genet Genomic Med; 2020 Apr; 8(4):e1154. PubMed ID: 32022462
[TBL] [Abstract][Full Text] [Related]
19. Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.
Scherer T; Allegri G; Sarkissian CN; Ying M; Grisch-Chan HM; Rassi A; Winn SR; Harding CO; Martinez A; Thöny B
J Inherit Metab Dis; 2018 Jul; 41(4):709-718. PubMed ID: 29520738
[TBL] [Abstract][Full Text] [Related]
20. Catalytic activity of tetrahydrobiopterin in dihydropteridine reductase deficiency and indications for treatment.
Ponzone A; Guardamagna O; Dianzani I; Ponzone R; Ferrero GB; Spada M; Cotton RG
Pediatr Res; 1993 Feb; 33(2):125-8. PubMed ID: 8433887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
